NMD4C at Ottawa NMD 2023
This September 7th to 9th the University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD) hosted the 6th Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023), with a program emphasizing recent breakthroughs in basic and translational research and clinical discoveries in neuromuscular disease. As a network, we had the opportunity to present three posters on the outcomes of select network activities from the first NMD4C grant period. Read the NMD4C abstracts here. All of the Ottawa NMD abstracts are also available on the event website. We also hosted a booth at the conference to share information on the network, recruit new members, and discuss our work with the many investigators and neuromuscular stakeholders who visited!
NMD4C Posters at Ottawa NMD 2023
- Compliance to Duchenne Muscular Dystrophy Care Considerations in Canada
- Expert Patient Capacity Building in Neuromuscular Disease Research
- The Neuromuscular Disease Network for Canada (NMD4C): An interdisciplinary national collaboration to tackle unmet needs for NMD research and care
Read the NMD4C abstracts here.
NMD4C Investigators that Presented at Ottawa NMD 2023
The three-day Ottawa NMD 2023 conference hosted nationally and internationally renowned basic researchers and clinicians to present talks highlighting advances in all aspects of NMD research, including new clinical diagnostic techniques, biology of disease pathogenesis, basic muscle and stem cell biology, and promising therapies to treat NMDs. Several network investigators delivered talks across the action-packed three-day program.
- Dr Craig Campbell: Duchenne Muscular Dystrophy Episignature
- Dr Natasha Chang: Muscle stem cell dysfunction in Duchenne muscular dystrophy
- Dr Gerald Pfeffer: Transcriptomic profiles and pathologic correlation in adult-onset myopathies
- Dr Hernan Gonorazky: MRI in the age of Artificial Intelligence
- Dr Mireille Khacho: Impact of Mitochondrial Dynamics on Muscle Stem Cell Function: Insights from Physiology, Diseases and Ageing
- Dr Hanns Lochmüller: Congenital myasthenic syndromes – diagnosis and therapy
- Dr Rami Massie: Update in autoimmune neuropathies
- Dr Hugh McMillan: Gene therapy in spinal muscular atrophy
- Dr Kerri Schellenberg: Clinical Updates in Spinal Bulbar Muscular Atrophy
- Dr Jodi Warman Chardon: Muscle Imaging in Genetic and Autoimmune Muscle Diseases
- Dr Nicolas Dumont: Clearance of defective muscle stem cells by senolytics reduces the expression of senescence associated secretory phenotype and restores myogenesis in myotonic dystrophy type 1
- Stacey Lintern / Dr Homira Osman: Opening remarks at Keynote Session
We are looking forward to Ottawa NMD 2025!
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.